CAS NO: | 143653-53-6 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
生物活性 |
Abciximab (C7E3), a chimeric mouse/human monoclonal antibody, is aglycoprotein(GP) IIb/IIIainhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to theglycoprotein IIb/IIIa, vitronectin and Mac-1 receptors[1]. |
||||||||
体外研究 (In Vitro) |
Abciximab (C7E3) inhibits platelet aggregation induced by physiologic and pathologic agonists by binding to the platelet αIIbβ3integrin[2].
|
||||||||
体内研究 (In Vivo) |
Abciximab (C7E3) (0.25 mg/kg/day; i.v.; 28 days) effectively prevents neointimal hyperplasia[2].
|
||||||||
Clinical Trial |
|
||||||||
CAS 号 |
143653-53-6 |
||||||||
中文名称 |
阿昔单抗 |
||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||
储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |